Alivas

About:

Alivas is a medical company that develops new therapeutic medical devices for refractory constipation.

Top Investors: UTokyo Innovation Platform, DBJ Capital, MedVenture Partners

Description:

Alivas is a medical company that develops new therapeutic medical devices for refractory constipation. It is a joint venture between Stanford University and the University of Tokyo with the Japan Biodesign program for innovative medical device creation. The company was founded in 2017 and is based in Hongo, Tokyo in Japan.

Total Funding Amount:

290M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hongo, Tokyo, Japan

Founded Date:

2017-08-30

Contact Email:

info(AT)alivas.co.jp

Founders:

Tajima Tomoyuki, Tomoyuki Tajima

Number of Employees:

1-10

Last Funding Date:

2020-07-20

IPO Status:

Private

Industries: